Electrophysiological Mechanisms and Inhibitory Cardiac Syncope — ELICA  

Syncope Recurrent Clinical Trial

Official title: ELectrophysiological Mechanisms Underlying the Inhibitory CArdiac Syncope: Therapeutic and Prognostic Implications The ELICA Study

Status Completed

Clinical Trial Summary

OBJECTIVES: To evaluate syncope recurrence at follow up in patients with a positive cardio inhibitory response to the head up tilt testing (HUT) evaluation.

METHODS: 36 consecutive patients affected by cardio inhibitory syncope to HUT without asystolia (2A type) have been enrolled in this study. These patients have been studied by electrophysiological study (ES). After ES patients have been differently treated (interventional treatment group A, v/s drug therapy group), and followed up during 360 days, to evaluate syncope recurrences.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Syncope
• Syncope Recurrent

• NCT number: NCT02861274
• Study type: Interventional
• Source: Second University of Naples
• Status: Completed
• Phase: Phase 1
• Start date: January 2010
• Completion date: September 2015